Donald Trump set off a new wave of controversy today, after publicly suggesting that acetaminophen—better known by the brand name Tylenol—may be linked to autism when used during pregnancy. Speaking at the White House alongside Health Secretary Robert F. Kennedy Jr. and TV doctor Mehmet Oz, Trump described the revelation as “one of the biggest medical discoveries in history” and urged pregnant women to avoid the drug.
Trump’s comments immediately sparked headlines. He framed his claim as “common sense,” noting that autism rates have increased in recent decades while Tylenol use during pregnancy has been widespread. He even compared U.S. autism rates with those of groups like the Amish and populations in Cuba, suggesting that lower autism prevalence in those communities could be explained by their limited access to acetaminophen.
Is Tylenol Truly the Cause?
The announcement triggered swift reactions from both the medical community and the pharmaceutical industry. Kenvue, the company that manufactures Tylenol, released a statement stressing that decades of scientific research and regulatory approval have demonstrated the drug’s safety. Health experts also pointed out that correlation does not equal causation: while some studies have found associations between acetaminophen use in pregnancy and neurodevelopmental outcomes, no definitive causal link has ever been proven.
The American College of Obstetricians and Gynecologists went further, calling the administration’s guidance “irresponsible.” The group warned that discouraging the use of acetaminophen could put pregnant women and their babies at risk, since untreated pain and fever during pregnancy can also lead to complications. Their advice was clear: until solid evidence proves otherwise, acetaminophen remains the safest pain relief option for expecting mothers.
Financial markets also reacted. Shares of Kenvue dropped after Trump’s remarks, reflecting investor anxiety over the potential impact of new government regulations or lawsuits tied to the claims.
Meanwhile, the White House promised that the FDA would review labeling requirements for acetaminophen products and issue new recommendations for doctors. Officials also pledged more research into the potential connection between the drug and autism.
@dailymail Trump announced Monday afternoon that Tylenol taken during pregnancy is linked to ‘a very increased risk of autism.’ Read more at DailyMail. #news #breakingnews #trump #autism #science
While his statements resonated with supporters who see him as a truth-teller challenging mainstream institutions, critics warn that unproven claims risk spreading confusion, undermining public trust, and even endangering public health.
For now, acetaminophen remains approved and widely recommended by doctors. But thanks to Trump’s intervention, a common household drug is suddenly at the center of America’s latest cultural and political storm.
